• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dual therapy with direct oral anticoagulants significantly increases the risk of stent thrombosis compared to triple therapy.

作者信息

Galli Mattia, Andreotti Felicita, D'Amario Domenico, Vergallo Rocco, Montone Rocco A, Porto Italo, Crea Filippo

机构信息

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy.

Università Cattolica del Sacro Cuore, Largo Agostino Gemelli 8, 00168 Rome, Italy.

出版信息

Eur Heart J Cardiovasc Pharmacother. 2020 Apr 1;6(2):128-129. doi: 10.1093/ehjcvp/pvz030.

DOI:10.1093/ehjcvp/pvz030
PMID:31309231
Abstract
摘要

相似文献

1
Dual therapy with direct oral anticoagulants significantly increases the risk of stent thrombosis compared to triple therapy.与三联疗法相比，直接口服抗凝剂的双联疗法显著增加了支架血栓形成的风险。
Eur Heart J Cardiovasc Pharmacother. 2020 Apr 1;6(2):128-129. doi: 10.1093/ehjcvp/pvz030.
2
Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis.双联或三联抗栓治疗患者的出血和缺血结局：系统评价和荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):226-236. doi: 10.1093/ehjcvp/pvz021.
3
Dual Versus Triple Antithrombotic Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: An Updated Meta-Analysis.急性冠状动脉综合征或经皮冠状动脉介入治疗后房颤患者的双联与三联抗栓治疗：一项更新的荟萃分析
Cardiovasc Revasc Med. 2020 Feb;21(2):239-241. doi: 10.1016/j.carrev.2019.08.015. Epub 2019 Aug 20.
4
Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.心房颤动和冠心病患者经皮冠状动脉介入治疗中的抗血栓治疗。
J Cardiovasc Pharmacol. 2019 Aug;74(2):82-90. doi: 10.1097/FJC.0000000000000697.
5
From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention.从治疗方案的选择到治疗强度的选择：接受经皮冠状动脉介入治疗的房颤患者抗栓治疗观念的转变
Cardiovasc Drugs Ther. 2020 Feb;34(1):143-144. doi: 10.1007/s10557-019-06903-y.
6
Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.经皮冠状动脉介入治疗的非瓣膜性心房颤动患者的当代抗栓治疗：希腊抗血小板心房颤动（GRAPE-AF）注册研究的原理和设计。
Cardiovasc Drugs Ther. 2018 Apr;32(2):191-196. doi: 10.1007/s10557-018-6789-7.
7
Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.AUGUSTUS试验中接受冠状动脉支架置入术的房颤患者的支架内血栓形成
Circulation. 2020 Mar 3;141(9):781-783. doi: 10.1161/CIRCULATIONAHA.119.044584. Epub 2019 Nov 11.
8
Will We Ever Decide What Antithrombotic Regimen to Use After Stenting?我们究竟何时才能确定支架置入术后使用何种抗血栓治疗方案？
Cardiovasc Revasc Med. 2020 May;21(5):702-703. doi: 10.1016/j.carrev.2020.05.026.
9
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗血栓治疗：北美视角-2018 年更新。
Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722.
10
A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.一项比较经皮冠状动脉介入治疗的心房颤动患者双联与三联抗栓治疗的随机试验的系统评价。
Catheter Cardiovasc Interv. 2020 Aug;96(2):E102-E109. doi: 10.1002/ccd.28535. Epub 2019 Nov 11.

引用本文的文献

1
Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation.房颤患者行经皮冠状动脉介入治疗后三联抗栓治疗的持续时间与临床结局。
Expert Rev Cardiovasc Ther. 2024 Jul;22(7):339-345. doi: 10.1080/14779072.2024.2374366. Epub 2024 Jul 1.
2
Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease With Recent or Remote Events: Systematic Review and Meta-analysis.近期或既往有事件的心房颤动合并冠状动脉疾病患者的抗栓治疗：系统评价和荟萃分析
CJC Open. 2024 Jan 12;6(5):708-720. doi: 10.1016/j.cjco.2024.01.001. eCollection 2024 May.
3
Antiplatelet therapy after percutaneous coronary intervention.
经皮冠状动脉介入治疗后的抗血小板治疗。
EuroIntervention. 2022 Apr 1;17(17):e1371-e1396. doi: 10.4244/EIJ-D-21-00904.
4
Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.心房颤动合并急性冠状动脉综合征且接受经皮冠状动脉介入治疗患者的抗栓策略
J Clin Med. 2022 Jan 20;11(3):512. doi: 10.3390/jcm11030512.
5
Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention.替格瑞洛用于经皮冠状动脉介入治疗后房颤患者的抗栓治疗
Front Cardiovasc Med. 2021 Oct 12;8:745549. doi: 10.3389/fcvm.2021.745549. eCollection 2021.
6
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.高出血风险患者经皮冠状动脉介入治疗后双联抗血小板治疗与或不联合口服抗凝治疗:一项开放标签、随机、对照试验。
Circulation. 2021 Oct 12;144(15):1196-1211. doi: 10.1161/CIRCULATIONAHA.121.056680. Epub 2021 Aug 29.
7
Unmet Clinical Needs in Elderly Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation.老年非瓣膜性心房颤动患者接受直接口服抗凝剂预防卒中的未满足临床需求。
Adv Ther. 2021 Jun;38(6):2891-2907. doi: 10.1007/s12325-021-01769-9. Epub 2021 May 21.
8
Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.非维生素 K 拮抗剂口服抗凝剂双联抗栓治疗在经皮冠状动脉介入治疗的心房颤动患者中的安全性和疗效：系统评价和荟萃分析。
J Am Heart Assoc. 2020 Aug 18;9(16):e017212. doi: 10.1161/JAHA.120.017212. Epub 2020 Aug 1.
9
Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal.心房颤动合并急性冠状动脉综合征/经皮冠状动脉介入治疗中双联与三联抗栓治疗的随机试验和荟萃分析：一项批判性评估。
Int J Cardiol Heart Vasc. 2020 May 14;28:100524. doi: 10.1016/j.ijcha.2020.100524. eCollection 2020 Jun.